ANI Pharmaceuticals Inc (ANIP)

Short-term

Turnover ratios

ANI Pharmaceuticals Inc's activity ratios provide insights into how efficiently the company manages its assets and liabilities to generate revenue.

1. Inventory turnover:
- ANI Pharmaceuticals Inc's inventory turnover has shown a fluctuating trend over the years, ranging from 1.23 to 1.83. The higher inventory turnover ratios in 2024 indicate that the company is selling its inventory more quickly, which is generally a positive sign as it reduces the risk of obsolescence and holding costs.

2. Receivables turnover:
- The data shows that receivables turnover information is unavailable for all years reviewed. This lack of data makes it challenging to assess how effectively the company collects payments from its customers.

3. Payables turnover:
- Similarly, the payables turnover data is also missing for all years, making it difficult to evaluate how efficiently the company manages its trade payables and cash flow.

4. Working capital turnover:
- The working capital turnover ratios range from 0.92 to 2.27, with an increase in the ratio observed in the latest year. A higher working capital turnover ratio indicates that ANI Pharmaceuticals Inc is efficiently utilizing its working capital to generate revenue, implying better operational efficiency.

Overall, while the inventory turnover and working capital turnover ratios provide some insight into ANI Pharmaceuticals Inc's operational efficiency, the lack of data for receivables and payables turnover limits a comprehensive analysis of the company's overall activity management.

---

Average number of days

ANI Pharmaceuticals Inc's activity ratios provide insight into how efficiently the company manages its operations.

1. Days of Inventory on Hand (DOH):
- Over the years, ANI Pharmaceuticals Inc has shown a fluctuating trend in its inventory management efficiency.
- The days of inventory on hand increased from 254.63 days in 2020 to 296.37 days in 2021 but then decreased to 199.53 days in 2024.
- A lower number of days indicates that the company is selling inventory quickly, while a higher number may indicate overstocking or low sales.

2. Days of Sales Outstanding (DSO):
- The data provided does not include information on days of sales outstanding, which is the average number of days it takes for a company to collect revenue after a sale.
- Lack of data on DSO makes it challenging to assess how effectively the company is managing its accounts receivable.

3. Number of Days of Payables:
- Similar to DSO, the information on the number of days of payables is not available for ANI Pharmaceuticals Inc.
- A higher number of days of payables may indicate that the company is taking longer to pay its suppliers, potentially benefiting from better cash flow management.

Overall, based on the available data, ANI Pharmaceuticals Inc's inventory management efficiency has shown fluctuations, highlighting the importance of closely monitoring and optimizing operational activities to enhance overall performance.

---

Long-term

The Fixed Asset Turnover ratio measures the efficiency with which a company utilizes its fixed assets to generate sales. A higher Fixed Asset Turnover ratio implies better asset utilization. In the case of ANI Pharmaceuticals Inc:

1. The Fixed Asset Turnover ratio decreased from 5.05 in December 2020 to 4.10 in December 2021, indicating a decrease in the company's ability to generate sales using its fixed assets efficiently.

2. However, there was a significant improvement in the Fixed Asset Turnover ratio from 4.10 in December 2021 to 7.32 in December 2022, suggesting a substantial increase in the efficiency of utilizing fixed assets to generate sales during this period.

3. Unfortunately, the data for December 2023 and December 2024 are not available (denoted as "—"), making it challenging to assess the trend for these years.

On the other hand, the Total Asset Turnover ratio evaluates the company's effectiveness in using all its assets to generate sales revenue. A higher Total Asset Turnover ratio indicates better overall asset utilization. For ANI Pharmaceuticals Inc:

1. The Total Asset Turnover ratio declined from 0.45 in December 2020 to 0.28 in December 2021, signifying a decrease in the company's ability to generate sales relative to its total assets.

2. There was a slight recovery in the Total Asset Turnover ratio from 0.28 in December 2021 to 0.42 in December 2022, suggesting an improvement in the efficiency of asset utilization to generate sales.

3. The ratio further increased to 0.54 in December 2023, indicating a better utilization of assets to generate sales revenue.

4. However, the Total Asset Turnover ratio declined slightly to 0.48 in December 2024, which could signify a dip in asset efficiency compared to the previous year.

In conclusion, ANI Pharmaceuticals Inc experienced fluctuations in its Fixed Asset Turnover and Total Asset Turnover ratios over the years, with significant improvements in some periods but with some uncertainty due to missing data points. These ratios provide insights into the company's operational efficiency and asset management strategies.